Glioblastoma (GBM) is the most common primary malignant brain tumor with a high mortality
rate. The current treatment consists of surgical resection, radiation, and chemotherapy; …

Background: Hypofractionated radiotherapy (HFR) is sometimes used in the treatment of
glioblastoma multiforme (GBM). The efficacy and safety of HFR is still under investigation …

Introduction NRG protocols for glioblastoma allow for clinical target volume (CTV) reductions
at natural barriers; however, literature examining CTV contouring and the relevant white …

Purpose To analyze recurrence patterns in patients with glioblastoma (GBM) after standard
chemoradiation according to different target volume delineation strategies. Methods and …

Introduction This study proposes contouring recommendations for radiation treatment
planning target volumes and organs-at-risk (OARs) for both low grade and high grade …

Introduction Maximal safe surgical resection followed by adjuvant chemoradiation has been
standard for newly diagnosed glioblastoma multiforme (GBM). Hypofractionated accelerated …

Background The optimal treatment volume for Glioblastoma multiforme (GBM) is still a
subject of debate worldwide. The current study was aimed to determine the distances …

Background Malignant transformation represents the natural evolution of diffuse low-grade
gliomas (LGG). This is a catastrophic event, causing neurocognitive symptoms, intensified …

Bis (2-chloroethyl)-1-nitrosourea (BCNU, or Carmustine) wafers are intraoperatively
implantable wafers used to achieve local tumor control. There is scarce data about the …

Aim and Background. Inoperable high‐grade gliomas (HGGs) comprise a specific group of
brain tumors portending a very poor prognosis. In the absence of surgical management …